BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23032478)

  • 1. Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease.
    Munro CA; Longmire CF; Drye LT; Martin BK; Frangakis CE; Meinert CL; Mintzer JE; Porsteinsson AP; Rabins PV; Rosenberg PB; Schneider LS; Weintraub D; Lyketsos CG;
    Am J Geriatr Psychiatry; 2012 Dec; 20(12):1036-44. PubMed ID: 23032478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.
    Lyketsos CG; DelCampo L; Steinberg M; Miles Q; Steele CD; Munro C; Baker AS; Sheppard JM; Frangakis C; Brandt J; Rabins PV
    Arch Gen Psychiatry; 2003 Jul; 60(7):737-46. PubMed ID: 12860778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.
    Banerjee S; Hellier J; Dewey M; Romeo R; Ballard C; Baldwin R; Bentham P; Fox C; Holmes C; Katona C; Knapp M; Lawton C; Lindesay J; Livingston G; McCrae N; Moniz-Cook E; Murray J; Nurock S; Orrell M; O'Brien J; Poppe M; Thomas A; Walwyn R; Wilson K; Burns A
    Lancet; 2011 Jul; 378(9789):403-11. PubMed ID: 21764118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer's disease.
    Magai C; Kennedy G; Cohen CI; Gomberg D
    Am J Geriatr Psychiatry; 2000; 8(1):66-74. PubMed ID: 10648297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of sertraline, venlafaxine and desipramine effects on depression, cognition and the daily living activities in Alzheimer patients.
    Mokhber N; Abdollahian E; Soltanifar A; Samadi R; Saghebi A; Haghighi MB; Azarpazhooh A
    Pharmacopsychiatry; 2014 Jul; 47(4-5):131-40. PubMed ID: 24955552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive response to pharmacological treatment for depression in Alzheimer disease: secondary outcomes from the depression in Alzheimer's disease study (DIADS).
    Munro CA; Brandt J; Sheppard JM; Steele CD; Samus QM; Steinberg M; Rabins PV; Lyketsos CG
    Am J Geriatr Psychiatry; 2004; 12(5):491-8. PubMed ID: 15353387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's Disease Study 2.
    Flynn Longmire CV; Drye LT; Frangakis CE; Martin BK; Meinert CL; Mintzer JE; Munro CA; Porsteinsson AP; Rabins PV; Rosenberg PB; Schneider LS; Weintraub D; Lyketsos CG;
    Am J Geriatr Psychiatry; 2014 Jan; 22(1):14-24. PubMed ID: 24314887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sertraline and Mirtazapine Versus Placebo in Subgroups of Depression in Dementia: Findings From the HTA-SADD Randomized Controlled Trial.
    Zuidersma M; Chua KC; Hellier J; Voshaar RO; Banerjee S;
    Am J Geriatr Psychiatry; 2019 Sep; 27(9):920-931. PubMed ID: 31084994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS-2)?
    Drye LT; Martin BK; Frangakis CE; Meinert CL; Mintzer JE; Munro CA; Porsteinsson AP; Rabins PV; Rosenberg PB; Schneider LS; Weintraub D; Lyketsos CG;
    Int J Geriatr Psychiatry; 2011 Jun; 26(6):573-83. PubMed ID: 20672243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.
    Weintraub D; Rosenberg PB; Drye LT; Martin BK; Frangakis C; Mintzer JE; Porsteinsson AP; Schneider LS; Rabins PV; Munro CA; Meinert CL; Lyketsos CG;
    Am J Geriatr Psychiatry; 2010 Apr; 18(4):332-40. PubMed ID: 20220589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in cognitive functioning in depressed older adults following treatment with sertraline or nortriptyline.
    Culang-Reinlieb ME; Sneed JR; Keilp JG; Roose SP
    Int J Geriatr Psychiatry; 2012 Aug; 27(8):777-84. PubMed ID: 21919060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury.
    Lee H; Kim SW; Kim JM; Shin IS; Yang SJ; Yoon JS
    Hum Psychopharmacol; 2005 Mar; 20(2):97-104. PubMed ID: 15641125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of depression in advanced Alzheimer's disease using sertraline.
    Volicer L; Rheaume Y; Cyr D
    J Geriatr Psychiatry Neurol; 1994; 7(4):227-9. PubMed ID: 7826491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sertraline treatment of elderly patients with depression and cognitive impairment.
    Devanand DP; Pelton GH; Marston K; Camacho Y; Roose SP; Stern Y; Sackeim HA
    Int J Geriatr Psychiatry; 2003 Feb; 18(2):123-30. PubMed ID: 12571820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
    De Jesus Moreno Moreno M
    Clin Ther; 2003 Jan; 25(1):178-93. PubMed ID: 12637119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and safety of sertraline versus nortriptyline in major depression in patients 70 and older.
    Finkel SI; Richter EM; Clary CM
    Int Psychogeriatr; 1999 Mar; 11(1):85-99. PubMed ID: 10189602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study.
    Mohs RC; Shiovitz TM; Tariot PN; Porsteinsson AP; Baker KD; Feldman PD
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):752-9. PubMed ID: 19700948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial.
    Brunoni AR; Machado-Vieira R; Zarate CA; Valiengo L; Vieira EL; Benseñor IM; Lotufo PA; Gattaz WF; Teixeira AL
    Psychopharmacology (Berl); 2014 Apr; 231(7):1315-23. PubMed ID: 24150249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden.
    Feldman H; Gauthier S; Hecker J; Vellas B; Emir B; Mastey V; Subbiah P;
    J Am Geriatr Soc; 2003 Jun; 51(6):737-44. PubMed ID: 12757558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.